ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 163062 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 163062; 2) Community: the network communities that were significantly associated with the response to NSC 163062; 3) Molecule: the relationships between components within communities and NSC 163062; 4) MDR: the compounds that were significantly associated with the NSC 163062.

NSC Compound Enrichment Correlation
NSC 618261 2H-1-Benzopyran, 6-methoxy-3-nitro-2-[2,2,2',2'-tetramethyl (4,4'-bi-1,3-dioxolan)-5-yl]- 2.25450366277245e-005 0.29252671
NSC 645991 Null 2.25450366277245e-005 0.44682181
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 2.25450366277245e-005 0.41653537
NSC 139105 Soluble Baker's Antifol 2.25450366277248e-005 0.22693302
NSC 134459 Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) 3.32248636628198e-006 0.36431507
NSC 619837 Null 3.59672078575118e-005 0.094328543
NSC 9594 Safranin bluish 3.59672078575118e-005 0.20776275
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 3.76935167005674e-007 0.44545203
NSC 629749 .beta.-Lapachone 5.09419714526523e-005 0.23884053
NSC 678989 Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-, cis- 5.09419714526523e-005 0.27819025
Total:156  Current:155    [First] [Prev] [Next] [Last]